CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 53 filers reported holding CYTEK BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $412 | +45.1% | 48,244 | +56.1% | 0.08% | +92.3% |
| Q1 2023 | $284 | -30.2% | 30,912 | -22.5% | 0.04% | -37.1% |
| Q4 2022 | $407 | -99.9% | 39,904 | -5.7% | 0.06% | -34.0% |
| Q3 2022 | $623,000 | +37.2% | 42,336 | +0.1% | 0.09% | +16.0% |
| Q2 2022 | $454,000 | +43.7% | 42,292 | +44.3% | 0.08% | +55.8% |
| Q1 2022 | $316,000 | -40.2% | 29,311 | -9.3% | 0.05% | -42.2% |
| Q4 2021 | $528,000 | – | 32,327 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |